Target intelligence / Profile preview

HIVEP zinc finger 2 (HIVEP2)

Target
HIVEP2
Molecular classification
Transcription factor, Zinc finger protein, DNA-binding protein
01

Overview

HIVEP zinc finger 2 (HIVEP2) is a large human zinc finger transcription factor that binds directly to DNA, including enhancer elements of the major histocompatibility complex (MHC) and the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR). It contains multiple C2H2-type zinc finger domains and is known by several aliases, reflecting its roles in immune regulation and transcriptional control. HIVEP2 can downregulate the NF-κB pathway, a key transcriptional pathway for immune and inflammatory responses, and has been implicated in neural and developmental functions. Pathogenic variants in HIVEP2 cause a recognizable neurodevelopmental syndrome characterized by intellectual disability, developmental delay, and behavioral abnormalities. There are no approved drugs targeting HIVEP2 directly, and it is principally studied as a transcriptional regulator rather than a traditional drug target. Key information is deduced from UniProt, NCBI Gene, and relevant scientific literature. No specific drugs, mechanisms of action, or biomarker roles are described in current high-quality sources.

Other names
Transcription factor HIVEP2HIV-EP2MIBP1ZAS2Schnurri-2ZNF40BHuman immunodeficiency virus type I enhancer-binding protein 2MHC-binding protein 2c-myc intron binding protein 1SHN2MRD43
02

Biological functions

Regulation of transcriptionDNA bindingImmune response modulation (including NF-κB signaling repression)Developmental processes
03

Disease associations

Neurodevelopmental disorder (mutations in HIVEP2 associated with intellectual disability and developmental delay)Potential involvement in immune-related diseases through NF-κB pathway modulation
04

Safety considerations

Mutations in HIVEP2 have been linked to neurodevelopmental disorders, including intellectual disability and developmental delay, raising concerns for CNS effects if modulated

Beyond the preview

Go deeper on HIVEP zinc finger 2 (HIVEP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIVEP zinc finger 2 (HIVEP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call